– Guidance 2020 fully met: Group performance on target
– Order book at new record level of EUR 4,977.0 million as of December 31, 2020 (previous year: EUR 4,692.0 million)
– Good sales development despite Covid-19 pandemic: Group sales of EUR 6,156.7 million -11.2% below previous year (previous year: EUR 6,936.5 million)
– Solid earnings level: EBITDA down -16.7% at EUR 1,106.9 million (previous year: EUR 1,328.7 million), EBITDA margin down to 18.0% compared to 19.2% in previous year
– Very strong free cash flow: EUR 729 million
– RVS division increased EBITDA margin to 22.9%, up 60 basis points from 22.3% in the previous year
– CVS division with solid EBITDA margin of 13.5% (previous year: 15.4%) thanks to rapid market recovery
– Outlook for 2021: sales EUR 6,500 to EUR 6,900 million, EBITDA margin corridor 17.5% to 19.0%, EBIT margin between 13.0% and 14.5%